Table 1. Stereoselectivity of Methyl Aryldiazoacetate Cyclopropanations of 1,1-Diarylethylenes
entry
R1
R2
R3
product
yield, %
ratio 6:7
6, % ee
7, % ee
1a
2
3
4b
5b
6
H
NO2
H
H
NO2
H
H
H
H
H
H
H
H
Cl
OMe
a
b
c
d
e
f
87
90
84
75
80
94
84
97
95
99
92
93
99
98
55:45
87:13
76:24
88:12
89:11
90:10
91
96
88
74
95
94
OMe
NHAc
OMe
OMe
OMe
7
H
g
a For a similar reaction using Rh2(S-TBSP)4 as catalyst, see ref 6. b Solvent was pentane/CH2Cl2.
exceptionally high levels of enantioselectivity (97% ee) are
obtained when 1,1-diphenylethylene is the substrate for these
cyclopropanations.6 To extend this reaction to the synthesis
of the tamoxifen analogue 2, unsymmetrical 1,1-diaryleth-
ylenes would need to be used, and therefore, issues of
diastereoselectivity in addition to enantioselectivity would
need to be addressed.
To evaluate the stereochemical issues of this chemistry,
the Rh2(S-DOSP)4-catalyzed reaction of methyl aryldiazoac-
etates with a series of 1,1-diarylethylenes was examined and
the results are summarized in Table 1. For most of the
reactions, pentane was used as the solvent, because it has
been found to give the highest enantioselectivity in Rh2(S-
DOSP)4-catalyzed cyclopropanations between 3 and styrene.5
For 1-(4-acetamidophenyl)-1-phenylethylene and 1-(4-meth-
oxyphenyl)-1-(4-nitrophenyl)ethylene, pentane/CH2Cl2 was
used as solvent due to their poor solubility in pentane.
The first group of reactions was carried out using methyl
phenyldiazoacetate (3) as the carbenoid precursor (entries
1-5), so that the effect of modifications to the 1,1-
diarylethylene could be determined.7 A very interesting effect
of electron-donating substituents on the diastereoselectivity
of these reactions was observed. Even though the reaction
of 1-(4-nitrophenyl)-1-phenylethylene gave essentially a 1:1
mixture of diastereomers (dr ) 55:45, entry 2), the reaction
with 1-(4-methoxyphenyl)-1-phenylethylene was consider-
ably more diastereoselective, resulting in a 87:13 mixture
of 6c and 7c (entry 3). Similar effects were seen with 1-(4-
acetamidophenyl)-1-phenylethylene (dr ) 76:24, entry 4) and
also with 1-(4-methoxyphenyl)-1-(4-nitrophenyl)ethylene (dr
) 88:12, entry 5).
To study the electronic effects of the aryl group in the
carbenoid intermediate on the diastereoselectivity, (4-chlo-
rophenyl)diazoacetate and (4-methoxyphenyl)diazoacetate
were tried next (entries 6 and 7). The diastereoselectivity
and enantioselectivity obtained with these substrates were
virtually the same as was obtained with methyl phenyldi-
azoacetate (entry 3).
The enantioselectivity of the cyclopropanation was found
to be good to excellent. Especially, high ee’s (98-99% ee)
were observed for the major diastereomer derived from 1-(4-
methoxyphenyl)-1-phenylethylene (entries 3, 6, and 7). The
ee’s were found to be slightly lower with 1-(4-acetami-
dophenyl)-1-phenylethylene (92% ee, entry 4) and 1-(4-
methoxyphenyl)-1-(4-nitrophenyl)ethylene (93% ee, entry 5).
This is probably because CH2Cl2/pentane was used as solvent
with these substrates, as polar solvents lower the enantio-
selectivity in Rh2(S-DOSP)4-catalyzed cyclopropanation of
styrene with aryldiazoacetates.8
To probe further the cause of the diastereoselectivity of
these reactions, the reactions between methyl phenyldi-
azoacetate and 1-[4-(2-chloroethoxy)phenyl]-1-phenylethyl-
ene 8 were conducted using several rhodium(II) catalysts in
CH2Cl2 (Table 2). In the case of Rh2(OAc)4, a fairly moderate
diastereoselectivity (64:36) was obtained, favoring 9-E (entry
1). The diastereoselectivity was slightly improved with the
more electron deficient catalyst Rh2(TFA)4 (70:30, entry 2)
(3) (a) Abidi, S. M. A.; Howard, E. W.; Dmytryk, J. J.; Pent, J. T. Clin.
Exp. Metathesis 1998, 16, 235. (b) Rajah, T. T.; Dunn, S. T.; Pento, J. T.
Anticancer Res. 1996, 16, 837. (c) Jain, P. T.; Pento, J. T.; Magarian, R.
A. Cancer Chemother. Pharmacol. 1996, 38, 238. (d) Day, B. W.; Magarian,
R. A.; Jain, P. T.; Pento, J. T.; Mousissian, G. K.; Meyer, K. L. J. Med.
Chem. 1991, 34, 842. (e) Bedford, G. R.; Walpole, A. L.; Wright, B. J.
Med. Chem. 1974, 17, 147.
(4) (a) Davies, H. M. L. Aldrichimica Acta 1997, 30, 107. (b) Davies,
H. M. L. Eur. J. Org. Chem. 1999, 2459.
(5) Davies, H. M. L.; Bruzinski, P. R.; Fall, M. J. Tetrahedron Lett. 1996,
37, 4133.
(6) Doyle, M. P.; Zhou, Q.-L.; Charnsangavej, C.; Longoria, M. A.;
McKervey, M. A.; Garcia, C. F.. Tetrahedron Lett. 1996, 37, 4129
(7) The relative configuration of 6 and 7 was determined by NOE. The
absolute configuration is tentatively assigned by analogy to related reactions,
see ref 4 and Moye-Sherman, D.; Welch, M. B.; Reibenspies, J.; Burgess,
K. J. Chem. Soc., Chem. Commun. 1998, 2377.
(8) Davies, H. M. L.; Bruzinski, P. R.; Lake, D. H.; Kong, N.; Fall, M.
J. J. Am. Chem. Soc. 1996, 118, 6897.
824
Org. Lett., Vol. 2, No. 6, 2000